Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DW-1030 and Eperisone HCl for acute back pain has completed. The document does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain

Drugs mentioned

• DW-1030
• Eperisone HCl (eperisone hydrochloride)

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Acute Back Pain | Phase 3 | Status: COMPLETED